V. Bryan Lawlis, Director at BIOMARIN PHARMACEUTICAL INC (BMRN), sold 3,750 shares at $90.00 ($338K) on 2017-06-16, disclosed to the SEC on 2017-06-20.
Seasonal sale ($338k) by Director — this insider has traded BMRN in June in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| GERN | SELL | 2023-05-11 | $105K | — | Filing → |
| BMRN | SELL | 2023-04-04 | $825K | — | Filing → |
| BMRN | SELL | 2022-04-18 | $356K | — | Filing → |